Teleflex (NYSE:TFX) Stock Crosses Above 200 Day Moving Average – Should You Sell?

Teleflex Incorporated (NYSE:TFX)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $116.10 and traded as high as $119.62. Teleflex shares last traded at $119.1870, with a volume of 691,748 shares changing hands.

Wall Street Analyst Weigh In

Several brokerages have commented on TFX. Truist Financial raised their price target on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a report on Thursday, December 18th. Needham & Company LLC raised their price target on shares of Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a report on Thursday, February 26th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Friday, March 27th. Zacks Research downgraded shares of Teleflex from a “hold” rating to a “strong sell” rating in a report on Monday, March 2nd. Finally, Wells Fargo & Company lifted their price objective on shares of Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a report on Friday, February 27th. Three research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $139.00.

Teleflex Stock Performance

The company has a market cap of $5.27 billion, a PE ratio of -5.80, a PEG ratio of 0.74 and a beta of 0.84. The business’s 50-day moving average is $111.26 and its 200 day moving average is $116.10. The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.01 and a current ratio of 2.54.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The business had revenue of $569.00 million during the quarter, compared to analysts’ expectations of $912.57 million. During the same quarter in the previous year, the business earned $3.89 EPS. Teleflex’s revenue for the quarter was down 28.5% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th were given a $0.34 dividend. The ex-dividend date was Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. Teleflex’s payout ratio is presently -6.62%.

Hedge Funds Weigh In On Teleflex

Hedge funds have recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB increased its position in shares of Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 77 shares during the period. Banque Cantonale Vaudoise increased its position in shares of Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the period. Hantz Financial Services Inc. increased its position in shares of Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after buying an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Teleflex during the third quarter valued at about $35,000. Finally, V Square Quantitative Management LLC purchased a new position in shares of Teleflex during the fourth quarter valued at about $37,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.